Skip to content

The effect of sumac extract on blood glucose and lipid levels

Preparation Herbal hypoglycemic Capsules using aqueous processed extract of sumac (Rhus coriaria L.)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240126060811N1
Enrollment
70
Registered
2024-02-21
Start date
2024-01-19
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group:. Intervention 2: Control group:.

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria include being diagnosed with type 2 diabetes (diagnosis of diabetes with fasting blood sugar (FBS) = 125 or 2 hours glucose = 200 or glycosylated hemoglobin = 6), Glycosylated hemoglobin level of more than 7% despite treatment with glucose control drugs (metformin or glibenclamide in the last 2 months), age 20-60 years, signing the informed consent form, at least three months have passed since the onset of the disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Glucose. Timepoint: Before the start of the intervention and after the completion of the intervention. Method of measurement: by commercial kit and autoanalyzer.

Secondary

MeasureTime frame
Serum cholesterol levels. Timepoint: Before the start of the intervention and at the end of the intervention. Method of measurement: By commercial kit and autoanalyzer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Asgarirad

Mazandaran University of Medical Sciences

Dr_Asgarirad@yahoo.com+98 11 3229 4882

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026